Squarepoint’s Chembio diagnostics, Inc. CEMI Stock Holding History

Squarepoint’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-38,608	Closed	-$97K	–	3701
2021 Q3	$97K	Sell	38,608 -26,901	-41%	-$74.6K	﹤0.01%	2678
2021 Q2	$195K	Buy	+65,509	New	+$228K	﹤0.01%	2845
2021 Q1	–	Sell	-106,886	Closed	-$508K	–	3897
2020 Q4	$508K	Buy	+106,886	New	+$552K	﹤0.01%	1804
2019 Q4	–	Sell	-11,426	Closed	-$70K	–	2991
2019 Q3	$70K	Sell	11,426 -7,281	-39%	-$43.4K	﹤0.01%	2221
2019 Q2	$114K	Buy	+18,707	New	+$126K	﹤0.01%	2208

Other funds holding CEMI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

EGM

Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Squarepoint's CEMI Position: Q4 2021 in Review

Squarepoint sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2021, closing a stake of 38,608 shares — an estimated $97K sold.

Squarepoint first reported a position in CEMI in Q2 2019 and held it in 5 quarters. The position peaked at $508K in Q4 2020. 43 funds tracked by Wall St. Rank hold CEMI as of Q4 2021.

Squarepoint reported no remaining Chembio diagnostics, Inc. position as of Q4 2021 after selling out during the quarter.
Squarepoint sold 38,608 Chembio diagnostics, Inc. shares in Q4 2021, an estimated $97K.
Squarepoint first reported a position in Chembio diagnostics, Inc. in Q2 2019 and held it in 5 quarters.
Squarepoint's Chembio diagnostics, Inc. position peaked at $508K in Q4 2020.
43 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2021.

Based on Squarepoint's 13F filing for Q4 2021, filed 14 Feb 2022.